Home   Chapter Home   Jobs   Conferences   Fellowships   Books

 

 

Advertisement

 

 

CD Markers

CD243

 

Authors: Kara Hamilton, M.S., Nat Pernick, M.D., PathologyOutlines.com, Inc.

Revised: 21 September 2012, last major update April 2010

Copyright: (c) 2002-2012, PathologyOutlines.com, Inc.

 

Definition

=========================================================================

● "Detoxifying agent" that pumps toxins / drugs out of cells, also transports steroid hormones and transports substances across blood-brain barrier

● Also mediates the ATP-driven efflux of drugs from multidrug-resistant cancer and HIV-infected cells.

 

Terminology

=========================================================================

● P glycoprotein is product of MDR1 gene

● Also called MDR-1 gene (multidrug resistance to cancer), P glycoprotein 170 (molecular weight is 170K), ABCB1, P-binding cassette subfamily B member 1

● Antibody C219 binds to both ATP-binding regions of P-glycoprotein and inhibits its ATPase activity and drug binding capacity; widely used as a tumor marker, but cross-reacts with HER2/c-erbB2 (Proc Natl Acad Sci USA 1999;96:13679)

● Antibody C494 detects an internal cellular epitope present only on the Mdr1 isoform of P-glycoprotein with strong plasma membrane staining patterns; it cross reacts with pyruvate carboxylase, an abundant mitochondrial enzyme (weak, homogeneous, cytoplasmic or granular patterns), but unlike C219, it does not cross react with Mdr3.

● Antibody JSB-1 appears to have similar behavior as C494, as it cross reacts with pyruvate carboxlyase (J Histochem Cytochem 1995;43:1187)

 

Pathophysiology

=========================================================================

● Assumed to function as ATP-dependent drug efflux pump with broad substrate specificity

● Member of large superfamily of highly conserved ATP binding cassette transport proteins

● Regulated by Y-box binding protein 1 (Clin Cancer Res 1998;4:2273)

● May regulate cholesterol trafficking in cells (Proc Natl Acad Sci USA 2002;99:10347)

Levels reduced in inflamed intestinal epithelium of patients with GI disorders (Inflamm Bowel Dis 2007;13:710)

Specific polymorphisms affect gene expression and mRNA processing (AAPS J 2006;8:E515)

Present in plasma membranes, not mitochondrial membranes (Exp Cell Res 2007;313:3100)

 

Clinical information

=========================================================================

Specific polymorphism associations: ulcerative colitis (Hum Mol Genet 2006;15:797), Parkinson’s disease-reduced risk (Arch Neurol 2005;62:460); response to chemotherapy in small cell lung cancer (Jpn J Clin Oncol 2006;36:137)

 

Uses

=========================================================================

MDR1 expression is poor prognostic factor in these malignancies:

- acute lymphoblastic leukemia - childhood (Oncol Rep 2004;12:1201) and adult types (Blood 2002;100:974)

- acute myelogenous leukemia - CD34 related coexpression of MDR1 and BCRP in patients age 60+ years (Ann Hematol 2007;86:329)

- acute promyelocytic leukemia in relapse (Haematologica 2002;87:1109)

- hepatocellular carcinoma-response to chemotherapy (World J Gastroenterol 2006;12:868)

- HIV related non-Hodgkin’s lymphoma (Pathol Res Pract 2007;203:1)

- lung and ovarian carcinoma (J Natl Cancer Inst 1992;84:1486)

- melanoma of uvea (Hum Pathol 1998;29:594)

- nasopharyngeal carcinoma (Hum Pathol 2001;32:1240)

- neuroblastoma (N Engl J Med 1991;325:1608)

- osteosarcoma (Int J Oncol 2006;29:1459)

- renal cell carcinoma (BMC Cancer 2006;6:293)

- soft tissue sarcoma-all ages (Hum Pathol 2005;36:994) and in children (J Clin Oncol 1990;8:689)

- Wilm’s tumor-staining of endothelial cells (Am J Clin Pathol 2002;117:484)

 

Positive stains - normal

=========================================================================

● Typically expressed in cells with excretory and secretory functions

May cross react with myosin

Also expressed in:

- adrenal cortex (Acta Pathol Jpn 1990;40:545)

- brain endothelium (Exp Biol Med (Maywood) 2005;230:118)

- bronchi (Eur Respir J 1997;10:1837)

- duodenum-lateral and apical surfaces (Drug Metab Dispos 2005;33:1603)

- heart-vascular endothelium (J Histochem Cytochem 2002;50:1351)

- kidney-proximal tubules (Nephron 1997;77:284)

- liver-bile canaliculi (Arch Otolaryngol Head Neck Surg 1993;119:753)

- lung (J Clin Pathol 2002;55:332), lung-type I alveolar epithelium (J Pharmacol Exp Ther 2003;304:441)

- lymphocytes-CD4+ (Blood 1992;80:2735)

- placenta

- retina (Mol Vis 2002;8:422)

- testicular endothelium

- white blood cells (Blood 1994;83:2451)

 

Positive stains - not malignant

=========================================================================

● drug-resistant epileptic human brain (BMC Med 2004 Oct 9;2:37);

 

Positive stains - malignancies

=========================================================================

● May cross react with HER2/c-erbB2

● AML-M6 (Mod Pathol 2000;13:407)

see also malignancies above under “MDR1 expression is poor prognostic factor

 

Micro images

=========================================================================

 

Normal tissues

                   

Duodenum (fig C/D)            Lung #1 (fig 1A)        #2 (fig D/E)

 

Retinal pigment epithelium

 

 

Carcinoma 

      

Bladder                    Breast #1                 #2 (fig 1-7)

 

 

      

Hepatocellular carcinoma #1;  #2                       Renal cell

(globular intracytoplasmic staining)

 

 

      

Retinoblastoma #1;  #2                            Immunofluorescence

(cytoplasmic staining)

 

Additional references

=========================================================================

OMIM 171050, Oncogene 2003;22:7468, Wikipedia

 

End of CD Markers > CD243

 

 

This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must also be interpreted in the context of a patient's clinical data using reasonable medical judgment.  This website should not be used as a substitute for the advice of a licensed physician.

 

All information on this website is protected by Copyright, (c) 2001-2009, PathologyOutlines.com, Inc.  Information from third parties may also be protected by copyright.  Please contact us at copyrightPathOut@gmail.com with any questions.